FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night driving impairment in ...
Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75% as a ...
Hosted on MSN5d
Pinellas mother of boy with rare metabolic disorder pushes for more accessible medical foodA Pinellas County mom is pushing for more accessible medical food for her 4-year-old son diagnosed with a rare metabolic disorder.
Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback